Firstly, data from Icelandic participants in the European Pharmacogenetic Opioid Study (EPOS) were used (N = 150).
Í fyrsta lagi, voru gögn frá íslenskum þátttakendum í European Pharmacogenetic Opioid Study (EPOS) rannsökuð (N = 150).